ZA84375B - Human tpa production using vectors coding for dhfr protein - Google Patents

Human tpa production using vectors coding for dhfr protein

Info

Publication number
ZA84375B
ZA84375B ZA84375A ZA84375A ZA84375B ZA 84375 B ZA84375 B ZA 84375B ZA 84375 A ZA84375 A ZA 84375A ZA 84375 A ZA84375 A ZA 84375A ZA 84375 B ZA84375 B ZA 84375B
Authority
ZA
South Africa
Prior art keywords
vectors coding
tpa production
dhfr protein
human tpa
tpa
Prior art date
Application number
ZA84375A
Other languages
English (en)
Inventor
Arthur David Levinson
Christian Clinton Simonsen
Elizabeth Mcleod Yelverton
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA84375B publication Critical patent/ZA84375B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Electrotherapy Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
ZA84375A 1983-01-19 1984-01-18 Human tpa production using vectors coding for dhfr protein ZA84375B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45915383A 1983-01-19 1983-01-19

Publications (1)

Publication Number Publication Date
ZA84375B true ZA84375B (en) 1985-02-27

Family

ID=23823628

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA84375A ZA84375B (en) 1983-01-19 1984-01-18 Human tpa production using vectors coding for dhfr protein

Country Status (12)

Country Link
EP (1) EP0117059B1 (fr)
JP (1) JPS59183693A (fr)
KR (1) KR840007255A (fr)
AT (1) ATE59410T1 (fr)
AU (1) AU572108B2 (fr)
CA (1) CA1271149A (fr)
DE (1) DE3483839D1 (fr)
DK (1) DK174081B1 (fr)
ES (1) ES529023A0 (fr)
IE (1) IE56716B1 (fr)
MY (1) MY101958A (fr)
ZA (1) ZA84375B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) * 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
GB8415186D0 (en) * 1984-06-14 1984-07-18 Ciba Geigy Ag Polypeptides
EP0174835A1 (fr) * 1984-09-11 1986-03-19 The Upjohn Company Activateur de plasminogène tissulaire humain et combinaisons d'ADN recombinant
EP0178105B1 (fr) * 1984-10-01 1997-04-02 Genzyme Corporation Techniques d'ADN recombinant et produits ainsi obtenus
GR860875B (en) * 1985-04-04 1986-07-29 Beecham Group Plc Novel compounds
US5672502A (en) * 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
JPH0714341B2 (ja) * 1985-11-20 1995-02-22 鐘淵化学工業株式会社 蛋白質の高生産株の取得方法
US4927630A (en) * 1986-02-26 1990-05-22 Monsanto Company Tissue plasminogen activator from normal human colon cells
US4751084A (en) * 1986-02-26 1988-06-14 Monsanto Company Tissue plasminogen activator from normal human colon cells
US5132214A (en) * 1986-04-09 1992-07-21 Monsanto Company Large scale production of plasminogen activator from normal human colon cells
US4851517A (en) * 1986-02-26 1989-07-25 Monsanto Company Tissue plasminogen activator oligosaccharide from normal human colon cells
CA1297434C (fr) * 1986-04-14 1992-03-17 Kenji Murakami Methode pour la production de peptides et de plasmides recombinants, destines a etre utilises dans les cellules animales transformees avec ce produit
JP2585532B2 (ja) * 1986-05-10 1997-02-26 三井東圧化学株式会社 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてｔ−ＰＡを生産する方法
JPS62265992A (ja) * 1986-05-12 1987-11-18 Ajinomoto Co Inc ヒト細胞を用いる有用物質の製造方法
PT84991B (pt) * 1986-06-06 1990-03-08 Genentech Inc Processo para a producao de actividador do plasminogenio biologicamente activo
JPS63105675A (ja) * 1986-10-23 1988-05-10 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
PT86162B (pt) * 1986-11-21 1990-11-20 Smithkline Beecham Corp Expressao de proteina recombinante
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
EP0281246A3 (fr) * 1987-02-04 1989-07-12 Invitron Corporation Procédé pour améliorer l'amplification et l'expression de gènes étrangers
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
US5013653A (en) * 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US5215896A (en) * 1987-03-20 1993-06-01 Creative Biomolecules, Inc. Leader sequences for the production of recombinant proteins
US5681713A (en) * 1987-05-08 1997-10-28 Smithkline Beecham Corporation Expression of heterologous proteins in Drosophila cells
CA1341345C (fr) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression de genes etrangers dans des cellules de drosophile
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5017478A (en) * 1987-07-16 1991-05-21 Berlex Laboratories, Inc. Transfected cells containing plasmids having genes oriented in opposing directions and methods of using
EP0322049B1 (fr) * 1987-12-21 1993-04-07 Unilever N.V. Catalyseurs de type nickel sur silice et leur préparation
EP0555203B1 (fr) * 1988-12-08 1995-10-18 Abbott Laboratories Procede d'expression d'une proteine par induction grace au gene dihydrofolate reductase (dhfr)
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5733761A (en) * 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
EP2258843B1 (fr) 2008-02-27 2016-11-16 National University Corporation Hokkaido University Vecteur d'expression pour la production en masse d'une protéine dérivée d'un gène étranger utilisant une cellule animale et son utilisation
CN102325881B (zh) 2008-12-22 2014-08-20 国立大学法人北海道大学 用于用动物细胞大量生产源自外源基因的蛋白质的表达载体及其应用
HRP20200768T4 (hr) 2009-08-11 2025-03-28 F. Hoffmann - La Roche Ag Proizvodnja proteina u mediju za uzgoj stanica bez glutamina
RU2500817C1 (ru) * 2012-07-19 2013-12-10 Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК рВК415, КОДИРУЮЩАЯ ПОЛИПЕПТИД РЕКОМБИНАНТНОГО ТКАНЕВОГО АКТИВАТОРА ПЛАЗМИНОГЕНА ЧЕЛОВЕКА, ЛИНИЯ КЛЕТОК Cricetulus griseus CHO 1F8 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ТКАНЕВОГО АКТИВАТОРА ПЛАЗМИНОГЕНА ЧЕЛОВЕКА И СПОСОБ ПОЛУЧЕНИЯ И ВЫДЕЛЕНИЯ ПОЛИПЕПТИДА, ОБЛАДАЮЩЕГО АКТИВНОСТЬЮ ТКАНЕВОГО АКТИВАТОРА ПЛАЗМИНОГЕНА
PL3137595T3 (pl) 2014-04-29 2019-09-30 Novartis Ag Nowe komórki kręgowców i sposoby ekspresji rekombinowanej polipeptydu będącego przedmiotem zainteresowania
US11781146B2 (en) 2018-05-24 2023-10-10 National University Corporation Hokkaido University Vector including a translation-impaired dihydrofolate reductase gene cassette and ubiquitously acting chromatin opening element

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
JPS5879205A (ja) * 1981-11-06 1983-05-13 Canon Inc 色分解用フイルタ−の製造方法
GR79202B (fr) * 1982-05-05 1984-10-22 Genentech Inc
AU2353384A (en) * 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
JPS61185427A (ja) * 1985-02-13 1986-08-19 Toyoda Gosei Co Ltd 射出装置
JPS6423654A (en) * 1987-07-17 1989-01-26 Fujitsu Ltd Pre-emphasis circuit

Also Published As

Publication number Publication date
AU2353484A (en) 1984-07-26
DK21184D0 (da) 1984-01-18
DK21184A (da) 1984-08-24
ATE59410T1 (de) 1991-01-15
ES8507610A1 (es) 1985-10-01
IE56716B1 (en) 1991-11-20
DK174081B1 (da) 2002-05-27
ES529023A0 (es) 1985-10-01
EP0117059A2 (fr) 1984-08-29
IE840097L (en) 1984-07-19
KR840007255A (ko) 1984-12-06
MY101958A (en) 1992-02-15
EP0117059A3 (en) 1986-03-05
EP0117059B1 (fr) 1990-12-27
JPS59183693A (ja) 1984-10-18
CA1271149A (fr) 1990-07-03
DE3483839D1 (de) 1991-02-07
AU572108B2 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
ZA84375B (en) Human tpa production using vectors coding for dhfr protein
DE3479321D1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby
DK181286D0 (da) Mutanter af human vaevplasminogenaktivator (t-pa), dna-sekvenser, som koder for disse, udtrykkelsesvektorer, som kan udtrykke dna-sekvenserne, mikroorganismer og cellekulturer transformeret med vektorerne og farmaceutiske praeparater af t-pa-mutanterne
HUT46065A (en) Process for producing new human tnf polypeptide mutants and dna encoding them
ZA871267B (en) A superoxide dismutase
DK0998568T3 (da) Mutant med uracil phosphoribosyltransferaseaktivitet
ATE110936T1 (de) Manganarmes proteinreiches reismehl.
HUT56884A (en) Process for producing protein having urate oxidase activity, gene coding for it, expression vector, microorganisms and transformed cells
IL80960A0 (en) Process for improving the expression of eukaryotic proteins
GB2181741B (en) Enhancement of plasminogen activator production using heparin or low molecular weight heparin and an endothelial growth factor
Sumi et al. Higher fibrin-binding and thrombolytic properties of single polypeptide chain-high molecular weight urokinase
ATE194624T1 (de) Mutanten von menschlichem antithrombin iii
AU1778988A (en) Novel fibrinolytic enzymes
NZ224243A (en) Single chain urokinase type plasminogen activator with yeast type glycosylation and site directed mutants thereof
FI894657A0 (fi) Menetelmä ihmiskudostyyppisen plasminogeeniaktivaattorin tuottamiseksi
Levinson et al. Human TPA production using vectors coding for DHFR protein
ES2013184A6 (es) Un procemiento para producir un activador de plasminogeno de tipo tejido (t-pa) mejorado.